• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名接受重组白细胞介素-2和淋巴因子激活的杀伤细胞过继免疫疗法的患者发生间质性肾炎。

Interstitial nephritis in a patient receiving adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells.

作者信息

Feinfeld D A, D'Agati V, Dutcher J P, Werfel S B, Lynn R I, Wiernik P H

机构信息

Department of Medicine, Nassau County Medical Center, East Meadow, N.Y.

出版信息

Am J Nephrol. 1991;11(6):489-92. doi: 10.1159/000168365.

DOI:10.1159/000168365
PMID:1819216
Abstract

A patient receiving adoptive immunotherapy with recombinant interleukin-2 (IL-2) and lymphokine-activated killer (LAK) cells for metastatic melanoma developed acute renal insufficiency out of proportion to the decrease in her renal perfusion after 4 days of receiving IL-2. On the 8th day of IL-2 and the 3rd day of LAK cell infusion she expired suddenly from an acute intra-abdominal hemorrhage due to rupture of a metastasis. Postmortem examination of the kidneys showed an interstitial infiltrate consisting largely of lymphocytes and concomitant tubulitis. Immunoperoxidase staining of the infiltrating cells with a panel of lymphocyte-specific monoclonal antibodies showed the majority of cells to be T lymphocytes (70-75%), with a more focal infiltrate of B lymphocytes (25-30%) and rare monocytes, granulocytes and natural killer cells. This patient represents the first reported case of acute interstitial nephritis associated with IL-2 immunotherapy. Our finding is consistent with the hypothesis that the acute renal failure that accompanies this therapy may sometimes be due to intrinsic renal disease as well as the usual pre-renal failure. Nephritis may be caused by IL-2-mediated effects on lymphocytes, resulting in renal parenchymal infiltration.

摘要

一名接受重组白细胞介素-2(IL-2)和淋巴因子激活的杀伤细胞(LAK)进行过继性免疫治疗的转移性黑色素瘤患者,在接受IL-2治疗4天后出现了与肾脏灌注减少不成比例的急性肾功能不全。在使用IL-2的第8天和输注LAK细胞的第3天,她因一处转移灶破裂导致急性腹腔内出血而突然死亡。肾脏的尸检显示,间质浸润主要由淋巴细胞组成,并伴有肾小管炎。用一组淋巴细胞特异性单克隆抗体对浸润细胞进行免疫过氧化物酶染色显示,大多数细胞为T淋巴细胞(70 - 75%),B淋巴细胞有更局灶性的浸润(25 - 30%),罕见单核细胞、粒细胞和自然杀伤细胞。该患者是首例报道的与IL-2免疫治疗相关的急性间质性肾炎病例。我们的发现与这样的假说一致,即这种治疗伴随的急性肾衰竭有时可能是由于内在的肾脏疾病以及常见的肾前性肾衰竭。肾炎可能是由IL-2对淋巴细胞的介导作用引起的,导致肾实质浸润。

相似文献

1
Interstitial nephritis in a patient receiving adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells.一名接受重组白细胞介素-2和淋巴因子激活的杀伤细胞过继免疫疗法的患者发生间质性肾炎。
Am J Nephrol. 1991;11(6):489-92. doi: 10.1159/000168365.
2
Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.内源性和过继转移的A-NK细胞及T-LAK细胞在接种后48小时内持续在小鼠转移灶中积聚。
In Vivo. 1999 May-Jun;13(3):199-204.
3
Crescentic IgA glomerulonephritis following interleukin-2 therapy for hepatocellular carcinoma of the liver.白细胞介素-2治疗肝细胞癌后发生的新月体性IgA肾小球肾炎。
Am J Nephrol. 1991;11(6):493-6. doi: 10.1159/000168366.
4
Regional adoptive immunotherapy with interleukin-2 and lymphokine-activated killer (LAK) cells for liver metastases.采用白细胞介素-2和淋巴因子激活的杀伤细胞(LAK细胞)进行区域过继性免疫治疗肝转移瘤。
Eur J Cancer. 1994;30A(1):103-5. doi: 10.1016/s0959-8049(05)80028-0.
5
Phase Ib trial of pentoxifylline and ciprofloxacin in patients treated with interleukin-2 and lymphokine-activated killer cell therapy for metastatic renal cell carcinoma.己酮可可碱与环丙沙星用于接受白细胞介素-2和淋巴因子激活的杀伤细胞疗法治疗转移性肾细胞癌患者的Ib期试验。
Cancer Res. 1994 Jul 1;54(13):3436-41.
6
Exogenous interleukin 2 recruits in vitro lymphokine-activated killer activity by in vivo activated lymphocytes.外源性白细胞介素2通过体内活化的淋巴细胞募集体外淋巴因子激活的杀伤活性。
Cancer Res. 1991 May 1;51(9):2324-8.
7
Prolonged continuous intravenous infusion interleukin-2 and lymphokine-activated killer-cell therapy for metastatic renal cell carcinoma.持续静脉输注白细胞介素-2及淋巴因子激活的杀伤细胞疗法治疗转移性肾细胞癌。
J Clin Oncol. 1992 Jun;10(6):960-8. doi: 10.1200/JCO.1992.10.6.960.
8
Isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine-activated killer cells in the treatment of in-transit metastases from limb cutaneous melanoma.体外循环中采用白细胞介素-2和淋巴因子激活的杀伤细胞进行隔离灌注治疗肢体皮肤黑色素瘤的移行转移灶
Ann Surg Oncol. 1995 Jan;2(1):61-70. doi: 10.1007/BF02303704.
9
An explanation of the variable clinical response to interleukin 2 and LAK cells.关于白细胞介素2和淋巴因子激活的杀伤细胞的不同临床反应的解释。
Immunol Today. 1990 Apr;11(4):113-5. doi: 10.1016/0167-5699(90)90046-c.
10
Phase I trial of intraperitoneal recombinant interleukin-2/lymphokine-activated killer cells in patients with ovarian cancer.腹腔内注射重组白细胞介素-2/淋巴因子激活的杀伤细胞治疗卵巢癌的I期试验。
Cancer Res. 1990 Oct 1;50(19):6302-10.

引用本文的文献

1
Adverse Renal Effects of Anticancer Immunotherapy: A Review.抗癌免疫疗法的肾脏不良反应:综述
Cancers (Basel). 2022 Aug 23;14(17):4086. doi: 10.3390/cancers14174086.
2
Acute tubulointerstitial nephritis: phenotype of infiltrating cells and prognostic impact of tubulitis.急性肾小管间质性肾炎:浸润细胞的表型及肾小管炎的预后影响
Virchows Arch. 1996 Apr;428(1):5-12. doi: 10.1007/BF00192921.
3
Possible role for cytotoxic lymphocytes in the pathogenesis of acute interstitial nephritis after recombinant interleukin-2 treatment for renal cell cancer.
细胞毒性淋巴细胞在重组白细胞介素-2治疗肾细胞癌后急性间质性肾炎发病机制中的可能作用。
Cancer Immunol Immunother. 1993;36(3):210-3. doi: 10.1007/BF01741094.
4
Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer.白细胞介素-2。其药理学特性及在癌症患者中的治疗应用综述。
Drugs. 1993 Sep;46(3):446-514. doi: 10.2165/00003495-199346030-00009.